Commercialisation of Healthcare in Japan: Overview | Practical Law

Commercialisation of Healthcare in Japan: Overview | Practical Law

A Q&A guide to the commercialisation of healthcare in Japan.

Commercialisation of Healthcare in Japan: Overview

Practical Law Country Q&A 8-618-1750 (Approx. 21 pages)

Commercialisation of Healthcare in Japan: Overview

by Takaaki Nagashima, Tadahiko Yasukuni, Steven Bryan and Eita Asabuki, Nagashima Hashimoto & Yasukuni
Law stated as at 01 Mar 2021Japan
A Q&A guide to the commercialisation of healthcare in Japan.
This Q&A provides a high-level overview of the regulatory framework for the commercialisation of medical products in Japan. It covers the key requirements for manufacturing, marketing, and advertising medicines, biological medicines, medical devices, combination products and natural health products.